SCHEMBL7916366

SCHEMBL7916366

CC(C)CCC([C]=O)CCC(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19812676 0.87 GABRR1 (0.34)
SCHEMBL17205755 0.86 TRPM8 (0.34)
SCHEMBL8944983 0.82 LMNA (0.46) LMNA
SCHEMBL18339202 0.82 MAPT (0.39) CA1LMNA
SCHEMBL6141164 0.75
SCHEMBL19617485 0.75 OPRM1 (0.41) CA1LMNA
SCHEMBL7525622 0.73 CA1 (0.35) CA1ALDH1A1LMNA
SCHEMBL19616642 0.73 LMNA (0.42) CA1LMNA
SCHEMBL4988454 0.73 MAPT (0.41) CA1LMNA
SCHEMBL4921012 0.73 MAPT (0.41) CA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576465-A DEHYDROETHERIFICATION OF ACETALS OR KETALS BY HEATING HUELS AKTIENGESELLSCHAFT (DE) 1996-11-19 US claimed
US-5354911-A From diacetals; catalyst composed of acid and amine HOECHST AKTIENGESELLSCHAFT (DE) 1994-10-11 US claimed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-10695277-B2 Pro-fragrance composition AQDOT LIMITED (GB) 2020-06-30 US disclosed
US-20190046426-A1 PRO-FRAGRANCE COMPOSITION AQDOT LIMITED (GB) 2019-02-14 US disclosed
EP-3416729-A1 PRO-FRAGRANCE COMPOSITION Aqdot Limited (GB) 2018-12-26 EP disclosed
WO-2017141030-A1 PRO-FRAGRANCE COMPOSITION AQDOT LIMITED (GB) 2017-08-24 WO disclosed
US-6211416-B1 REACTING ACETAL OR KETAL WITH ACETYLENE OR ALLENE IN GAS PHASE IN PRESENCE OF CATALYST SELECTED FROM ZINC- OR CADMIUM-SILICON- AND OXYGEN-CONTAINING HETEROGENEOUS CATALYST BASF AKTIENGESELLSCHAFT (DE) 2001-04-03 US disclosed
US-5576465-A DEHYDROETHERIFICATION OF ACETALS OR KETALS BY HEATING HUELS AKTIENGESELLSCHAFT (DE) 1996-11-19 US disclosed
US-5354911-A From diacetals; catalyst composed of acid and amine HOECHST AKTIENGESELLSCHAFT (DE) 1994-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190046426-A1 PRO-FRAGRANCE COMPOSITION COPS5, COPS8, CBR3 CA1 2521/4885ALDH1A1 1526/4885LMNA 2903/4885
US-10695277-B2 Pro-fragrance composition COPS5, COPS8, CBR3 CA1 2521/4885ALDH1A1 1526/4885LMNA 2903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.